Cargando…

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19

Mostrar otras versiones (1)

BACKGROUND: Severe coronavirus disease 2019 (COVID-19) can manifest in rapid decompensation and respiratory failure with elevated inflammatory markers, consistent with cytokine release syndrome for which IL-6 blockade is an approved treatment. METHODS: We assessed effectiveness and safety of IL-6 bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Somers, Emily C, Eschenauer, Gregory A, Troost, Jonathan P, Golob, Jonathan L, Gandhi, Tejal N, Wang, Lu, Zhou, Nina, Petty, Lindsay A, Baang, Ji Hoon, Dillman, Nicholas O, Frame, David, Gregg, Kevin S, Kaul, Dan R, Nagel, Jerod, Patel, Twisha S, Zhou, Shiwei, Lauring, Adam S, Hanauer, David A, Martin, Emily, Sharma, Pratima, Fung, Christopher M, Pogue, Jason M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454462/ https://www.ncbi.nlm.nih.gov/pubmed/32651997 http://dx.doi.org/10.1093/cid/ciaa954

Ejemplares similares

Tocilizumab for treatment of mechanically ventilated patients with COVID-19
por: Somers, Emily C, et al.
Publicado: (2020)

Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants
por: Pogue, Jason M, et al.
Publicado: (2021)

1035. Implementation of an Antimicrobial Stewardship Program-Led, Multifactorial Pneumonia Diagnosis and Treatment Bundle
por: Cua, Jefferson L, et al.
Publicado: (2019)

A Multi-Faceted Antimicrobial Stewardship Program (ASP) Intervention Using Clinical Pharmacists Reduces Antibiotic Use and Hospital-Acquired Clostridium difficile Infection (HA-CDI)
por: Boyd, Anthony M, et al.
Publicado: (2017)

Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series
por: Breeden, Madison, et al.
Publicado: (2023)

1056. Evaluation of Clinical Outcomes Following Implementation of Real-Time Stewardship Team Interventions for Multi-Drug-Resistant Organisms
por: Xhemali, Xhilda, et al.
Publicado: (2019)

578. Infections in Patients Treated with Chimeric Antigen Receptor T-cells (CAR-T) therapy
por: Tran, Nikki, et al.
Publicado: (2020)

Antibiotic Overuse After Hospital Discharge: A Multi-hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2020)

1124. Impact of a Best Practice Advisory for Pediatric Patients with Staphylococcus aureus Bloodstream Infection
por: Lloyd, Elizabeth C, et al.
Publicado: (2019)

869. Evaluation of Broad-Spectrum Antibiotic De-Escalation in Patients with Health-Care Associated Pneumonia (HCAP) and No Microbiological Diagnosis
por: Patel, Twisha S, et al.
Publicado: (2018)

1517. Evaluation of Antibiotic Prescribing Practices for Lower Urinary Tract Infections in the Emergency Department
por: Lim, Megan, et al.
Publicado: (2018)

727. Evaluation of Antibiotic Prescribing Practices for Upper Respiratory Infections in the Adult and Pediatric Emergency Departments
por: Lim, Megan, et al.
Publicado: (2018)

Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
por: Petty, Lindsay A, et al.
Publicado: (2018)

Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2020)

1071. Impact of Standard vs. Prolonged Courses of Antibiotics for the Treatment of Uncomplicated Staphylococcus aureus Bacteremia (SAB) in Patients With Hematologic Malignancies
por: Cheung, Edna, et al.
Publicado: (2018)

2890. Antibiotic Overuse at Discharge in Hospitalized Patients with Bacteriuria or Treated for Pneumonia: A Multi-Hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2019)

2152. Epidemiology and Clinical Outcomes of Contemporary, Third-Generation Left Ventricular Assist Device (LVAD) Infections
por: Hershberger, Todd E, et al.
Publicado: (2018)

PB2206: PROGRESSION FACTORS OF MYELOFIBROSIS BASED ON CLINICAL FEATURES AND NEXT-GENERATION SEQUENCING LANDSCAPE OF ESSENTIAL THROMBOCYTHEMIA: A CHINES TWO-CENTER RETROSPECTIVE STUDY
por: Xiang, Danhong, et al.
Publicado: (2023)

Ganciclovir-resistant CMV (GCV-R CMV) Infection Leads to Poor Clinical Outcomes and Economic Burden of Ganciclovir-resistant Cytomegalovirus Infection in Lung Transplant Recipients
por: Patel, Twisha, et al.
Publicado: (2017)

When Infections Don’t Reflect Infectiousness: Interpreting Contact Investigation Data With Care
por: Kendall, Emily A
Publicado: (2020)

SARS-CoV-2 vaccines: a triumph of science and collaboration
por: Golob, Jonathan L., et al.
Publicado: (2021)

PB2211: DIFFERENCES IN POST-POLYCYTHEMIA VERA AND POST–ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS VS PRIMARY MYELOFIBROSIS IN FIBROTIC STAGE: A RETROSPECTIVE, REAL-WORLD STUDY CONDUCTED IN CHINA
por: Wang, Shengjie, et al.
Publicado: (2023)

1106. Assessment of Fluoroquinolone Appropriateness for Hospitalized Patients with Asymptomatic Bacteriuria and Cystitis: A Multi-Hospital Cohort Study
por: Gandhi, Tejal N, et al.
Publicado: (2019)

2222. Impact of Empiric Aminoglycoside Usage on Outcomes in Bacterial Pneumonia
por: Albin, Owen, et al.
Publicado: (2019)

792. Evaluation of Persistent Diarrhea and Recurrence Following Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
por: Boton, Noah, et al.
Publicado: (2020)

1083. Risk Factors Associated with Treatment of Asymptomatic Bacteriuria in the Emergency Department: A Multi-Hospital Cohort Study
por: Petty, Lindsay A, et al.
Publicado: (2019)

1467. Clinical Significance of Microbiologic Treatment Failure Following Clinical Cure of Pneumonia
por: Albin, Owen, et al.
Publicado: (2018)

159. Improving Antibiotic Use for Sinusitis and Upper Respiratory Tract Infections: A Virtual Visit Antibiotic Stewardship Initiative
por: Wasylyshyn, Anastasia, et al.
Publicado: (2021)

Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017–2018
por: Boikos, Constantina, et al.
Publicado: (2020)

1876. Patient- and Hospital-Level Factors and Outcomes Associated With Treatment of Asymptomatic Bacteriuria in Hospitalized Patients: A Multi-Hospital Cohort Study
por: Petty, Lindsay, et al.
Publicado: (2018)

PB2708: SYMPTOM BURDEN AND ITS IMPACT ON DAILY LIFE IN PATIENTS WITH IDIOPATHIC MULTICENTRIC CASTLEMAN’S DISEASE (IMCD): AN EXPLORATORY ANALYSIS OF THE SURVEY’S INTERNAL CONSTRUCT VALIDITY
por: Franklin, Matt, et al.
Publicado: (2023)

PB2495: QUANTIFICATION AND IMMUNOPHENOTYPIC CHARACTERISATION OF CAR T-CELLS BY FLOW CYTOMETRY AND CORRELATION WITH CLINICAL OUTCOMES FOR PATIENTS WITH LARGE B CELL LYMPHOMA
por: Wayte, Rebecca, et al.
Publicado: (2023)

PB1980: MULTIPLE MYELOMA: ADOPTING MRD BY NEXT GENERATION FLOW CYTOMETRY (NGF) AND FUNCTIONAL IMAGING GUIDED CONSOLIDATION INTO CLINICAL ROUTINE
por: Boeckle, D., et al.
Publicado: (2022)

It Is Time to Focus on Asymptomatic Tuberculosis
por: Wong, Emily B
Publicado: (2020)

PB2660: HEREDITARY COAGULATION FACTOR FVII DEFICIENCY CAUSED BY COMPOUND HETEROZYGOUS MUTATIONS
por: Zhou, Rongfu, et al.
Publicado: (2023)

PB1728: CRESCENDO IMPROVEMENT OF SURVIVAL FOR ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DURING PAST TWO DECADES: A 1000 CASES COHORT IN A SINGLE CENTER
por: Chen, Junjie, et al.
Publicado: (2023)

PB2516: ACTIGRAPHY IMPROVEMENT WITH VOXELOTOR (ACTIVE) STUDY: IMPACT OF VOXELOTOR ON PHYSICAL ACTIVITY, FATIGUE, AND SLEEP QUALITY
por: Shah, Nirmish, et al.
Publicado: (2023)

Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018–2019 Influenza Season in the United States
por: Boikos, Constantina, et al.
Publicado: (2021)

PB2441: CD34+ CELL DOSE EFFECTS ON CLINICAL OUTCOMES OF ALLO-HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)
por: Zhou, Shengnan, et al.
Publicado: (2023)

Cohort Profile: The Vukuzazi (‘Wake Up and Know Yourself’ in isiZulu) population science programme
por: Gunda, Resign, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_58nglign5ms1dd8o46rpgub0c4